FAV-201

Thuốc Gốc

Biotech

FAV-201 is a patient-specific immunotherapy for the treatment of T-cell lymphoma.

Dược Lực Học : FAV-201 is a recombinant, patient-specific, T-cell receptor-based immunotherapy designed to induce an active immune response against the unique protein found on the surface of T-cells that constitute a patient's lymphoma.

Chỉ Định : Investigated for use/treatment in lymphoma (non-hodgkin's).

Tài Liệu Tham Khảo Thêm

drugbank

http://www.drugbank.ca/drugs/DB06130

Bạn thấy hài lòng ?

Bạn chưa hài lòng ?

... loading